RARA and breast carcinoma: Early analysis on breast cancer cell lines showed that CRABP-II content in the cell was positively related to ATRA-growth inhibition, and that the ectopic CRABP-II enhanced ATRA action [71], and evidence showed that RARα drives CRABP-II transcription [72].